F.L. Putnam Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
EHC
SRIM
MG
OAM
F.L. Putnam Investment Management's NVO Position: Q2 2026 in Review
F.L. Putnam Investment Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,387 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #625 among its holdings. This is a return to the name: F.L. Putnam Investment Management previously reported a position in NVO as recently as Q4 2025.
F.L. Putnam Investment Management first reported a position in NVO in Q3 2020 and has held it in 18 quarters since. The position peaked at $785K in Q3 2024. 884 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- F.L. Putnam Investment Management held 4,387 shares of Novo Nordisk worth $210K as of Q2 2026.
- Novo Nordisk was a new F.L. Putnam Investment Management position in Q2 2026.
- Novo Nordisk made up ﹤0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #625 holding.
- F.L. Putnam Investment Management first reported a position in Novo Nordisk in Q3 2020 and has held it in 18 quarters since.
- F.L. Putnam Investment Management's Novo Nordisk position peaked at $785K in Q3 2024.
- 884 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.